Li, Zunling
Deng, Mi
Huang, Fangfang
Jin, Changzhu
Sun, Shuang
Chen, Heyu
Liu, Xiaoye
He, Licai
Sadek, Ali H.
Zhang, Cheng Cheng
Article History
Received: 30 May 2019
Accepted: 14 October 2019
First Online: 7 November 2019
Change Date: 31 January 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: C.C.Z. is a scientific founder of Immune-Onc Therapeutics. C.C.Z. and M.D. hold equity in and have multiple patents licensed to Immune-Onc Therapeutics. The other authors declare no competing interests.